Spire Healthcare Group plc (LON:SPI - Get Free Report) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 237.33 ($2.95) and traded as high as GBX 241 ($3.00). Spire Healthcare Group shares last traded at GBX 239 ($2.98), with a volume of 240,857 shares traded.
Analyst Upgrades and Downgrades
SPI has been the topic of several research analyst reports. JPMorgan Chase & Co. restated an "overweight" rating and issued a GBX 295 ($3.67) price target on shares of Spire Healthcare Group in a research report on Monday, February 26th. Berenberg Bank reissued a "buy" rating and set a GBX 286 ($3.56) price objective on shares of Spire Healthcare Group in a report on Thursday, February 29th.
Get Our Latest Stock Analysis on Spire Healthcare Group
Spire Healthcare Group Price Performance
The company has a quick ratio of 0.74, a current ratio of 0.69 and a debt-to-equity ratio of 170.37. The company's 50-day moving average is GBX 237.33 and its 200-day moving average is GBX 228.76. The stock has a market cap of £963.85 million, a price-to-earnings ratio of 3,400.00, a price-to-earnings-growth ratio of 1.06 and a beta of 0.99.
Spire Healthcare Group Increases Dividend
The business also recently disclosed a dividend, which will be paid on Friday, June 21st. Shareholders of record on Thursday, May 23rd will be paid a dividend of GBX 2.10 ($0.03) per share. This is a positive change from Spire Healthcare Group's previous dividend of $0.50. This represents a yield of 0.89%. The ex-dividend date is Thursday, May 23rd. Spire Healthcare Group's dividend payout ratio is currently 4,285.71%.
About Spire Healthcare Group
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Recommended Stories
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
